Distefano G, Baker A, Scott A J D, Webster G J
Department of Medical Physics, Royal Surrey County Hospital, Guildford, UK.
Br J Radiol. 2014 May;87(1037):20130681. doi: 10.1259/bjr.20130681. Epub 2014 Mar 13.
To ascertain the progress being made towards the implementation of stereotactic ablative body radiotherapy (SABR) treatment in the UK, to obtain details of current practice in centres with an active treatment programme and to assess the projected future provision.
In August 2012, an online questionnaire was sent to all 65 UK radiotherapy institutions. The included questions covered the current number of patients being treated and the intended number of patients for each clinical site; immobilization and motion management methods; CT scanning protocols; target and organ-at-risk delineation; treatment planning; image-guidance and treatment protocols; and quality assurance methods.
48/65 (74%) institutions responded by the end of November 2012, with 15 indicating an active SABR programme. A further four centres indicated that a SABR protocol had been established but was not yet in clinical use. 14 of the 29 remaining responses stated an intention to develop a SABR programme in the next 2 years.
The survey responses confirm that SABR provision in the UK is increasing and that this should be expected to continue in the next 2 years. A projection of the future uptake would suggest that by the end of 2014, UK SABR provision will be broadly in line with international practice.
确定英国在实施立体定向消融体部放疗（SABR）治疗方面取得的进展，获取开展积极治疗项目的中心的当前实践细节，并评估未来的预计供应情况。
2012年8月，向英国所有65家放疗机构发送了一份在线调查问卷。所包含的问题涵盖了当前各临床部位正在接受治疗的患者数量以及预期的患者数量；固定和运动管理方法；CT扫描方案；靶区和危及器官的勾画；治疗计划；图像引导和治疗方案；以及质量保证方法。
截至2012年11月底，48/65（74%）家机构做出了回应，其中15家表示有积极的SABR项目。另有4个中心表示已制定SABR方案，但尚未投入临床使用。其余29份回复中有14份表示打算在未来2年内开展SABR项目。
调查回复证实，英国的SABR供应正在增加，预计在未来2年仍将如此。对未来采用情况的预测表明，到2014年底，英国的SABR供应将大致与国际惯例接轨。
